Yue-qiu Gao

Shuguang, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Ferroptosis in liver fibrosis and its potential intervention strategy.

Ferroptosis in liver fibrosis and its potential intervention strategy.

Journal: Cell biology and toxicology

Published: June 14, 2025

Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis.

Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis.

Journal: Scientific reports

Published: December 12, 2023

Yin-chen Wu-ling powder alleviate cholestatic liver disease: Network pharmacological analysis and experimental validation.

Yin-chen Wu-ling powder alleviate cholestatic liver disease: Network pharmacological analysis and experimental validation.

Journal: Gene

Published: July 18, 2022

Amygdalin protects against acetaminophen-induced acute liver failure by reducing inflammatory response and inhibiting hepatocyte death.

Amygdalin protects against acetaminophen-induced acute liver failure by reducing inflammatory response and inhibiting hepatocyte death.

Journal: Biochemical and biophysical research communications

Published: January 25, 2022

Chemical characters and protective effect of Baqi Lingmao formula on experimental liver injury.

Chemical characters and protective effect of Baqi Lingmao formula on experimental liver injury.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

Published: December 23, 2021

Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.

Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.

Journal: Journal of ethnopharmacology

Published: December 17, 2021

Corrigendum to "Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients".

Corrigendum to "Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients".

Journal: Journal of immunology research

Published: December 12, 2021

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.

Journal: International journal of biological sciences

Published: November 09, 2021

Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: September 01, 2021

Synthesis and biological evaluation of fluorinated 3,4-dihydroquinolin-2(1H)-ones and 2-oxindoles for anti-hepatic fibrosis.

Synthesis and biological evaluation of fluorinated 3,4-dihydroquinolin-2(1H)-ones and 2-oxindoles for anti-hepatic fibrosis.

Journal: RSC advances

Published: November 05, 2020

Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.

Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.

Journal: Antiviral research

Published: August 04, 2020

DJ-1 Deficiency in Hepatocytes Improves Liver Ischemia-Reperfusion Injury by Enhancing Mitophagy.

DJ-1 Deficiency in Hepatocytes Improves Liver Ischemia-Reperfusion Injury by Enhancing Mitophagy.

Journal: Cellular and molecular gastroenterology and hepatology

Published: July 01, 2020

Showing 1-12 of 41

Last Updated: 09/26/2026